By Jennifer Chiou
New York, Oct. 11 - Ophthonix Inc. announced it obtained $17 million in series C financing.
InterWest Partners led investors, which included Enterprise Partners Venture Capital, Kleiner Perkins Caufield & Byers, Gund Investment Corp., Trex Enterprises and Wasatch Advisors.
"Our initial product launch in Southern California has been very successful; both consumers and eye doctors are very pleased and have reported excellent results," president and chief executive officer Andreas Dreher said in a news release.
"We anticipate continued strong market acceptance and a smooth rollout of our advanced vision correction technology across the rest of the U.S."
Based in San Diego, Ophthonix is an ophthalmic company that produces high-definition vision technology. The company has the Z-View Wavefront Aberrometer and iZon Wavefront-Guided Eyeglasses, which provide optical clarity.
Proceeds will further product commercialization and manufacturing capacity.
| Issuer: | Ophthonix Inc.
|
| Issue: | Preferred stock
|
| Amount: | $17 million
|
| Round: | Series C
|
| Investors: | InterWest Partners (lead), Enterprise Partners Venture Capital, Kleiner Perkins Caufield & Byers, Gund Investment Corp., Trex Enterprises, Wasatch Advisors
|
| Announcement date: | Oct. 11
|
|
|
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.
